300 related articles for article (PubMed ID: 16536739)
21. Overexpression of calsenilin enhances gamma-secretase activity.
Jo DG; Jang J; Kim BJ; Lundkvist J; Jung YK
Neurosci Lett; 2005 Apr; 378(1):59-64. PubMed ID: 15763173
[TBL] [Abstract][Full Text] [Related]
22. Unnatural amino acid-substituted (hydroxyethyl)urea peptidomimetics inhibit gamma-secretase and promote the neuronal differentiation of neuroblastoma cells.
Liao YF; Wang BJ; Hsu WM; Lee H; Liao CY; Wu SY; Cheng HT; Hu MK
Mol Pharmacol; 2007 Feb; 71(2):588-601. PubMed ID: 17105873
[TBL] [Abstract][Full Text] [Related]
23. Novel alpha-secretase cleavage of Alzheimer's amyloid beta precursor protein in the endoplasmic reticulum of COS7 cells.
Shin RW; Saido TC; Maeda M; Kitamoto T
Neurosci Lett; 2005 Mar; 376(1):14-9. PubMed ID: 15694266
[TBL] [Abstract][Full Text] [Related]
24. Widespread gamma-secretase activity in the cell, but do we need it at the mitochondria?
Teng FY; Tang BL
Biochem Biophys Res Commun; 2005 Mar; 328(1):1-5. PubMed ID: 15670741
[TBL] [Abstract][Full Text] [Related]
25. Nicastrin functions as a gamma-secretase-substrate receptor.
Shah S; Lee SF; Tabuchi K; Hao YH; Yu C; LaPlant Q; Ball H; Dann CE; Südhof T; Yu G
Cell; 2005 Aug; 122(3):435-47. PubMed ID: 16096062
[TBL] [Abstract][Full Text] [Related]
26. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
Harrison T; Churcher I; Beher D
Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
[TBL] [Abstract][Full Text] [Related]
27. Trafficking of amyloid β-precursor protein products C83 and C99 on the endocytic pathway.
Hare J
Biochem Biophys Res Commun; 2010 Oct; 401(2):219-24. PubMed ID: 20849818
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
29. Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding.
Wrigley JD; Nunn EJ; Nyabi O; Clarke EE; Hunt P; Nadin A; De Strooper B; Shearman MS; Beher D
J Neurochem; 2004 Sep; 90(6):1312-20. PubMed ID: 15341515
[TBL] [Abstract][Full Text] [Related]
30. Gamma-secretase-like cleavages of Notch and beta APP are mutually exclusive in human cells.
Petit A; St George-Hyslop P; Fraser P; Checler F
Biochem Biophys Res Commun; 2002 Feb; 290(5):1408-10. PubMed ID: 11820778
[TBL] [Abstract][Full Text] [Related]
31. The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.
Laudon H; Winblad B; Näslund J
Physiol Behav; 2007 Sep; 92(1-2):115-20. PubMed ID: 17588625
[TBL] [Abstract][Full Text] [Related]
32. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
33. Gamma-secretase activity is present in rafts but is not cholesterol-dependent.
Wada S; Morishima-Kawashima M; Qi Y; Misono H; Shimada Y; Ohno-Iwashita Y; Ihara Y
Biochemistry; 2003 Dec; 42(47):13977-86. PubMed ID: 14636066
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
35. COPI-mediated retrograde transport is required for efficient gamma-secretase cleavage of the amyloid precursor protein.
Selivanova A; Winblad B; Farmery MR; Dantuma NP; Ankarcrona M
Biochem Biophys Res Commun; 2006 Nov; 350(1):220-6. PubMed ID: 16999935
[TBL] [Abstract][Full Text] [Related]
36. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
37. The cytoplasmic sequence of E-cadherin promotes non-amyloidogenic degradation of A beta precursors.
Agiostratidou G; Muros RM; Shioi J; Marambaud P; Robakis NK
J Neurochem; 2006 Feb; 96(4):1182-8. PubMed ID: 16417575
[TBL] [Abstract][Full Text] [Related]
38. Gamma-secretase: a catalyst of Alzheimer disease and signal transduction.
Li YM
Mol Interv; 2001 Oct; 1(4):198-207. PubMed ID: 14993342
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
Iwatsubo T
Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
[TBL] [Abstract][Full Text] [Related]
40. Evidence that the amyloid-β protein precursor intracellular domain, AICD, derives from β-secretase-generated C-terminal fragment.
Flammang B; Pardossi-Piquard R; Sevalle J; Debayle D; Dabert-Gay AS; Thévenet A; Lauritzen I; Checler F
J Alzheimers Dis; 2012; 30(1):145-53. PubMed ID: 22406447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
